Pharmaceutical Technology

DECEMBER 9, 2022

In regards to the latter, notable examples include the acquisition of Cergentis, a genomics-focused biotechnology company based in the Netherlands. The deal allows the company to provide proprietary technology and knowledge steeped in fast-evolving genomic techniques that support effective decision-making and R&D program design.

Development 130

Development Production Manufacturing Vaccination 130

The Pharma Data

MAY 5, 2021

New variant-hardy AbCellera-Lilly mAb shows utility of viral genomics surveillance ( BioCentury ). BD Taps Contract Packager for COVID-19 Test Kits ( MD+DI ). Zimmer sees Q1 sales growth after CEO warned of down quarter ( MedTech Dive ). Medtech.

Vaccination 52

Vaccination Vaccine Gene Therapy Contract Packaging 52

The Pharma Data

AUGUST 6, 2020

NEW YORK–( BUSINESS WIRE )– Bristol Myers Squibb (NYSE:BMY) today reports results for the second quarter of 2020, which reflect strong product sales, continued advancement of the pipeline and robust operating performance. chairman and chief executive officer, Bristol Myers Squibb. In May, the company announced the U.S.

Production 52

Production Branding Marketing Licensing 52